[{"NetIncomeLoss_1_Q1_USD":-167250000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":8019000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":79454000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":180636000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":28278000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":50800000.0,"BilledContractReceivables_0_Q1_USD":117733000.0,"InterestPaidNet_1_Q1_USD":11688000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-3000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":156666000.0,"PrepaidExpenseNoncurrent_0_Q1_USD":2124000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":50800000.0,"AssetsCurrent_0_Q1_USD":2271350000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-2774000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":29989000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":71131000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":10300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4683000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":210000000.0,"CommonStockSharesIssued_0_Q1_shares":79748109.0,"Assets_0_Q1_USD":2765233000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-6000.0,"ShareBasedCompensation_1_Q1_USD":28508000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":65068000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PrepaidTaxes_0_Q1_USD":3930000.0,"Liabilities_0_Q1_USD":2229788000.0,"ShortTermInvestments_0_Q1_USD":255997000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":79454000.0,"AssetsFairValueDisclosure_0_Q1_USD":1453302000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-72000.0,"AccountsReceivableNetCurrent_0_Q1_USD":118203000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-143000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-22005000.0,"CommonStockValue_0_Q1_USD":8000.0,"Revenues_1_Q1_USD":146931000.0,"RestrictedCashAndInvestmentsNoncurrent_0_Q1_USD":9315000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q1_USD":28508000.0,"InterestPayableCurrent_0_Q1_USD":3182000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":8930000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":195149000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2893000.0,"CostsAndExpenses_1_Q1_USD":298796000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":1747100000.0,"OtherAssetsCurrent_0_Q1_USD":174981000.0,"IncreaseDecreaseInInventories_1_Q1_USD":8372000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-167256000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":170000.0,"OtherAssetsNoncurrent_0_Q1_USD":211584000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1481836000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":60675000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":3490658000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-6000.0,"DebtInstrumentFaceAmount_0_Q1_USD":1119993000.0,"CommonStockSharesAuthorized_0_Q1_shares":198000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":124926000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-167393000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q1_USD":22005000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-180371000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":62244000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":79454000.0,"LiabilitiesCurrent_0_Q1_USD":364736000.0,"AccountsPayableCurrent_0_Q1_USD":76651000.0,"NonoperatingIncomeExpense_1_Q1_USD":-15528000.0,"InterestExpense_1_Q1_USD":15651000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1490901000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":9226000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":3946000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-34915000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q1_shares":0.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":1156415000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":1490901000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q1_USD":3092000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":4543000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":14124000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":250000000.0,"GovernmentContractReceivable_0_Q1_USD":470000.0,"PrepaidInsurance_0_Q1_USD":2637000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":203107000.0,"RestrictedCashNoncurrent_0_Q1_USD":9065000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":5729000.0,"CommonStockSharesOutstanding_0_Q1_shares":79748109.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":16863000.0,"OperatingIncomeLoss_1_Q1_USD":-151865000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":255997000.0,"OtherNonoperatingExpense_1_Q1_USD":15528000.0,"OtherAssetsMiscellaneousCurrent_0_Q1_USD":5369000.0,"InventoryNet_0_Q1_USD":240333000.0,"InvestmentIncomeInterest_1_Q1_USD":59000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":89244000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2765233000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":23520000.0,"PreferredStockSharesAuthorized_0_Q1_shares":3333333.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q1_USD":149811000.0,"LongTermLoansPayable_0_Q1_USD":1091110000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q1_USD":869993000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q1_USD":-6000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":901000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.1,"ProfitLoss_1_Q1_USD":-167250000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":20984000.0,"OtherLiabilitiesCurrent_0_Q1_USD":18205000.0,"StockholdersEquity_0_Q1_USD":535445000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":641483000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":21149000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":55869000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2955218000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-20812000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":28508000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":10990000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]